| Balneotherapy in psoriasis rehabilitation I Péter, A Jagicza, Z Ajtay, I Boncz, I Kiss, K Szendi, P Kustán, B Németh in vivo 31 (6), 1163-1168, 2017 | 46 | 2017 |
| Nonconventional markers of sepsis P Kustán, Z Horváth-Szalai, D Mühl Ejifcc 28 (2), 122, 2017 | 26 | 2017 |
| Antagonistic sepsis markers: Serum gelsolin and actin/gelsolin ratio Z Horvath-Szalai, P Kustan, D Muehl, A Ludany, B Bugyi, T Kőszegi Clinical biochemistry 50 (3), 127-133, 2017 | 26 | 2017 |
| Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance P Kustan, B Szirmay, Z Horvath-Szalai, A Ludany, GL Kovacs, A Miseta, ... Clinical Chemistry and Laboratory Medicine (CCLM) 55 (2), 299-307, 2017 | 23 | 2017 |
| Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD M Tőkés-Füzesi, I Ruzsics, O Rideg, P Kustán, GL Kovács, T Molnár International Journal of Chronic Obstructive Pulmonary Disease, 3749-3757, 2018 | 19 | 2018 |
| Urinary orosomucoid a potential marker of inflammation in psoriasis P Kustán, T Kőszegi, A Miseta, I Péter, Z Ajtay, I Kiss, B Németh International Journal of Medical Sciences 15 (11), 1113, 2018 | 17 | 2018 |
| Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use P Kustán, B Szirmay, Z Horváth-Szalai, A Ludány, Á Lakatos, D Mühl, ... Biochemia medica 26 (3), 421-430, 2016 | 17 | 2016 |
| Predictive value of serum gelsolin and Gc globulin in sepsis–a pilot study Z Horváth-Szalai, P Kustán, B Szirmay, Á Lakatos, PH Christensen, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (8), 1373-1382, 2018 | 15 | 2018 |
| Angiotensin-converting enzyme inhibition improves the effectiveness of transcutaneous carbon dioxide treatment B Nemeth, I Kiss, T Jencsik, I Peter, Z Kreska, T Koszegi, A Miseta, ... in vivo 31 (3), 425-428, 2017 | 13 | 2017 |
| Novel automated immune turbidimetric assay for routine urinary cystatin-C determinations B Szirmay, P Kustan, Z Horváth-Szalai, A Ludány, A Lakatos, D Mühl, ... Bioanalysis 10 (6), 377-384, 2018 | 12 | 2018 |
| Monitoring of L-arginine and endogenous dimethylarginines in survivor septic patients–A pilot study B Nemeth, I Kiss, I Peter, Z Ajtay, A Nemeth, L Mark, A Csorba, T Kőszegi, ... in vivo 30 (5), 663-669, 2016 | 12 | 2016 |
| Validation of an automated immune turbidimetric assay for serum gelsolin and its possible clinical utility in sepsis Z Horváth‐Szalai, P Kustán, B Szirmay, Á Lakatos, PH Christensen, ... Journal of clinical laboratory analysis 32 (3), e22321, 2018 | 11 | 2018 |
| Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients? B Németh, I Péter, I Boncz, A Jagicza, I Kiss, Á Csergő, T Kőszegi, ... Therapeutics and Clinical Risk Management, 831-837, 2019 | 10 | 2019 |
| Microchip gel electrophoretic analysis of perchloric acid‐soluble serum proteins in systemic inflammatory disorders L Makszin, P Kustán, B Szirmay, C Páger, E Mező, KI Kalács, V Pászthy, ... Electrophoresis 40 (3), 447-454, 2019 | 9 | 2019 |
| Monitoring urinary orosomucoid in patients undergoing cardiac surgery: A promising novel inflammatory marker P Kustán, B Szirmay, T Kőszegi, A Ludány, GL Kovács, A Miseta, D Mühl, ... Clinical biochemistry 50 (18), 1002-1006, 2017 | 9 | 2017 |
| Human orosomucoid in the clinical laboratory P Kustán, B Szirmay, D Mühl, A Ludány Techniques with applicability in medical practice. Saarbrücken: LAP Lambert …, 2015 | 6 | 2015 |
| Urinary actin, as a potential marker of sepsis-related acute kidney injury: A pilot study D Ragán, P Kustán, Z Horváth-Szalai, B Szirmay, B Bugyi, A Ludány, ... Plos one 16 (7), e0255266, 2021 | 5 | 2021 |
| Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease B Szirmay, A Tárnok, P Sarlós, N Szigeti, A Ludány, P Kustán, ... European Journal of Clinical Investigation 49 (3), e13054, 2019 | 5 | 2019 |
| Asymmetric dimethylarginine: predictor of cardiovascular diseases? B Németh, P Kustán, Á Németh, Z Lenkey, A Cziráki, I Kiss, E Sulyok, ... Orvosi Hetilap 157 (13), 483-487, 2016 | 5 | 2016 |
| Aszimmetrikus dimetilarginin: a cardiovascularis betegségek prediktora? B Németh, P Kustán, Á Németh, Z Lenkey, A Cziráki, I Kiss, E Sulyok, ... Orvosi Hetilap 157 (13), 483-487, 2016 | 3 | 2016 |
